缩写名/全名 |
LEUKEMIA RES
LEUKEMIA RESEARCH |
||||||||||||||||||||||||
ISSN号 | 0145-2126 | ||||||||||||||||||||||||
研究方向 | 医学-血液学 | ||||||||||||||||||||||||
影响因子 | 2015:2.606, 2016:2.501, 2017:2.319, 2018:2.066, 2019:2.214, | ||||||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||
年文章数 | 98 | ||||||||||||||||||||||||
出版年份 | 1977 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-6周 来源Elsevier官网:平均7.7周 |
||||||||||||||||||||||||
录用比例 | 容易 | ||||||||||||||||||||||||
投稿链接 | http://ees.elsevier.com/lr/tempdown.asp | ||||||||||||||||||||||||
投稿官网 | http://www.journals.elsevier.com/leukemia-research/ | ||||||||||||||||||||||||
h-index | 81 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0145-2126%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1 Author: Li Li, Yixin Cui, Jinyan Shen, Hannah Dobson, Gongqin Sun Journal: LEUKEMIA RESEARCH, 2019, Vol.78, 12-20, DOI:10.1016/j.leukres.2019.01.006 DOI |
2. | A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia Author: Hong Luo, Suo Zhang, Ke Li, Xing-Hua Chen, Yan-Chun Li, Yuan Sun, Li-Feng Liu, Hui-Yang Yu, Hong-Hu Zhu Journal: LEUKEMIA RESEARCH, 2018, Vol.77, 14-16, DOI:10.1016/j.leukres.2018.12.009 DOI |
3. | LMO2 functional and transcriptional regulatory profiles in hematopoietic cells Author: Chao Wu, Mei Yuan, Yang Gao, Wei Sun Journal: LEUKEMIA RESEARCH, 2018, Vol.75, 11-14, DOI:10.1016/j.leukres.2018.10.013 DOI |
4. | MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression Author: Chen Huan, Lou Jin, Wang Heng, An Na, Pan Yuming, Du Xin, Zhang Qiaoxia Journal: LEUKEMIA RESEARCH, 2018, Vol.75, 1-6, DOI:10.1016/j.leukres.2018.10.012 DOI |
5. | Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI. Author: Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Journal: Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. PubMed |
6. | The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia. Author: Chen H, Wang N, Yang G, Guo Y, Shen Y, Wang X, Zhang P, Xu Y. Journal: Leuk Res. 2016 Mar;42:28-36. doi: 10.1016/j.leukres.2016.01.013. Epub 2016 Jan 28. PubMed |
7. | Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study. Author: Duan MH, Han X, Li J, Zhang W, Zhu TN, Han B, Zhuang JL, Wang SJ, Cao XX, Cai HC, Chen M, Yang C, Zhou DB. Journal: Leuk Res. 2016 Mar;42:43-6. doi: 10.1016/j.leukres.2016.01.012. Epub 2016 Jan 28. PubMed |
8. | CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients. Author: Li XM, Zhang LP, Wang YZ, Lu AD, Chang Y, Zhu HH, Qin YZ, Lai YY, Kong Y, Huang XJ, Liu YR. Journal: Leuk Res. 2016 Apr;43:33-8. doi: 10.1016/j.leukres.2015.12.015. Epub 2016 Jan 4. PubMed |
9. | SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis. Author: Zhu Y, Li X, Chang C, Xu F, He Q, Guo J, Tao Y, Liu Y, Liu L, Shi W. Journal: Leuk Res. 2016 May;44:8-16. doi: 10.1016/j.leukres.2016.02.011. Epub 2016 Feb 27. PubMed |
10. | Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells. Author: Geng S, Yao H, Weng J, Tong J, Huang X, Wu P, Deng C, Li M, Lu Z, Du X. Journal: Leuk Res. 2016 May;44:17-24. doi: 10.1016/j.leukres.2016.02.002. Epub 2016 Feb 16. PubMed |
|
|